Yaron Werber analyst TD COWEN

Currently out of the existing stock ratings of Yaron Werber, 128 are a BUY (72.73%), 47 are a HOLD (26.7%), 1 are a SELL (0.57%).

Yaron Werber

Work Performance Price Targets & Ratings Chart

Analyst Yaron Werber, currently employed at TD COWEN, carries an average stock price target met ratio of 64.79% that have a potential upside of 22.77% achieved within 387 days.

Yaron Werber’s has documented 349 price targets and ratings displayed on 40 stocks. The coverage is on Healthcare, Consumer Defensive sectors.

Most recent stock forecast was given on AMGN, Amgen at 05-Aug-2026.

Wall Street Analyst Yaron Werber

Analyst best performing recommendations are on GMAB (GENMAB AS).
The best stock recommendation documented was for ARGX (ARGENX NV ADR) at 7/17/2023. The price target of $533 was fulfilled within 3 days with a profit of $48.57 (10.03%) receiving and performance score of 33.42.

Average potential price target upside

AMGN Amgen ARGX argenx NV ADR BGNE BeiGene Ltd FGEN FibroGen RARE Ultragenyx XLRN Acceleron Pharma BLUE Bluebird bio EPZM Epizyme REGN Regeneron Pharmaceuticals ASND Ascendis Pharma AS ROIV Roivant Sciences Ltd TIL Instil Bio TSVT 2Seventy Bio EXEL Exelixis BNTX BioNTech SE GILD Gilead Sciences IOBT IO Biotech GBIO Generation Bio Co ORTX Orchard Therapeutics PLC GMAB Genmab AS IONS Ionis Pharmaceuticals LEGN Legend Biotech Corp STOK Stoke Therapeutics CELG Celgene COGT Cogent Biosciences PRVL Prevail Therapeutics SWTX SpringWorks Therapeutics ALEC Alector CLDX Celldex Therapeutics IMRX Immuneering Corp JSPR Jasper Therapeutics RAPT RAPT Therapeutics RLAY Relay Therapeutics  AGIO Agios Pharm BG Bunge BIIB Biogen CLVS Clovis Oncology FG F&G Annuities & Life ICPT Intercept Pharmaceuticals PBYI Puma Biotechnology

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold Since 06-Aug-2026

$345

$-59.85 (-14.78%)

$335

Buy Since 05-Aug-2026

$400

$-4.85 (-1.20%)

$330

Hold Since 10-Jan-2025

$400

$-4.85 (-1.20%)

$375

Buy Since 26-Jan-2026

$440

$35.15 (8.68%)

$420

Hold Since 24-Nov-2025

$362

$-42.85 (-10.58%)

$340

Show more analysts

Please expand the browser size to see the chart

Which stock is Yaron Werber is most bullish on?

Potential upside of $56.23 has been obtained for IONS (IONIS PHARMACEUTICALS)

Which stock is Yaron Werber is most reserved on?

Potential downside of $2.8 has been obtained for EXEL (EXELIXIS)

What Year was the first public recommendation made by Yaron Werber?

On 2008

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?